Irish patients excluded from drug trials for life-saving treatments due to barriers
Ireland attracting fewer clinical trials than some European countries
Ireland attracting fewer clinical trials than some European countries
Waiving patent rights may have chilling effect on medicine development, industry warns
Industry says waiver of IP rights not needed as vaccine supply far outweighs demand
Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021
Spending review says that confidential pricing deals make it more difficult for HSE to contain drug costs
Medicines regularly not worth approving at asking price
Upfront costs high but treatments may cut long-term expense and boost patient results
Company recorded 80 per cent increase in pretax profit to €8.59 million in 2019
New medicines have cut number of years of life lost to heart disease by 34% since 2005
Seen and Heard: construction lockdown slammed, Davy review to look at deals before Anglo
Deal with pharma sector comes as talks on new drug pricing deal deferred until May
Canada, Japan and South Korea warn against grab for vaccine supplies
Study finds high proportion of people willing to get immunised against coronavirus
State’s lack of a clear budget structure for medicines is a frustration for Big Pharma
Budget 2021 is a chance to address our poor performance in bringing medicines we make to our patients
Irish Pharmaceutical Healthcare Association seeks State accord on access to new therapies
Government and pharma companies agree space for discussions on longer-term pricing
Current agreement due to expire at the end of July after savings of about €600m
Four-year-old accord on supply and pricing of medicines is set to expire at end of July
Alert comes after US secures Covid-19 drug treatment for next three months
Pharma group says eight cancer therapies awaiting HSE approval for over 900 days
Almost half surveyed say cancer is the disease science has greatest potential to cure
Industry study tracks 15 drugs that have yet to be approved by the HSE for use in Irish hospitals
Ger Brennan, who runs the Irish operation of MSD, is Brexit-ready and focusing on other issues
Donohoe told Harris in August he wanted ban on new medicines for remainder of year
Christophe Weber has overseen the $62 billion takeover of Shire and the opening of a new plant in Dublin
PwC report on European drug sector highlights contributions to economy and society
Aidan Lyncht HSE should not be expected to pay for drugs that are not innovative
Pharmaceutical industry body suspected site may have been ‘compromised’
Study examines access to 121 drugs approved since 2015 by EU regulator
Medicines generally blocked on basis of price as Ipha says delay ‘unacceptably long’
Pharma body says less than one-third of medicines for rare diseases licensed for patients in Europe are available in the Republic
Row between industry and body that advises the HSE over access to market for new medicines
With an overall percentage drop in this year’s HSE budget, primary care’s minuscule share of health spend will continue
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices